Global Vaccine for Non-infectious Meningitis Market Growth 2025-2031
The global Vaccine for Non-infectious Meningitis market size is predicted to grow from US$ 1.4 million in 2025 to US$ 2.8 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine for Non-infectious Meningitis Industry Forecast” looks at past sales and reviews total world Vaccine for Non-infectious Meningitis sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine for Non-infectious Meningitis sales for 2025 through 2031. With Vaccine for Non-infectious Meningitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine for Non-infectious Meningitis industry.
This Insight Report provides a comprehensive analysis of the global Vaccine for Non-infectious Meningitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine for Non-infectious Meningitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine for Non-infectious Meningitis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine for Non-infectious Meningitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine for Non-infectious Meningitis.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Non-infectious Meningitis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vaccine for Non-infectious Meningitis market?
What factors are driving Vaccine for Non-infectious Meningitis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine for Non-infectious Meningitis market opportunities vary by end market size?
How does Vaccine for Non-infectious Meningitis break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine for Non-infectious Meningitis Industry Forecast” looks at past sales and reviews total world Vaccine for Non-infectious Meningitis sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine for Non-infectious Meningitis sales for 2025 through 2031. With Vaccine for Non-infectious Meningitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine for Non-infectious Meningitis industry.
This Insight Report provides a comprehensive analysis of the global Vaccine for Non-infectious Meningitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine for Non-infectious Meningitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine for Non-infectious Meningitis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine for Non-infectious Meningitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine for Non-infectious Meningitis.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Non-infectious Meningitis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Men B Vaccines
- Meningitis
- Septicemia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Serum Institute
- Sanofi SA
- Pfizer
- Nuron Biotech
- JN-International Medical
What is the 10-year outlook for the global Vaccine for Non-infectious Meningitis market?
What factors are driving Vaccine for Non-infectious Meningitis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine for Non-infectious Meningitis market opportunities vary by end market size?
How does Vaccine for Non-infectious Meningitis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine for Non-infectious Meningitis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine for Non-infectious Meningitis by Country/Region, 2020, 2024 & 2031
2.2 Vaccine for Non-infectious Meningitis Segment by Type
2.2.1 Polysaccharide Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Combination Vaccines
2.2.4 Men B Vaccines
2.3 Vaccine for Non-infectious Meningitis Sales by Type
2.3.1 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine for Non-infectious Meningitis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Type (2020-2025)
2.4 Vaccine for Non-infectious Meningitis Segment by Application
2.4.1 Meningitis
2.4.2 Septicemia
2.4.3 Others
2.5 Vaccine for Non-infectious Meningitis Sales by Application
2.5.1 Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine for Non-infectious Meningitis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine for Non-infectious Meningitis Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine for Non-infectious Meningitis Breakdown Data by Company
3.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine for Non-infectious Meningitis Sales Market Share by Company (2020-2025)
3.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Company (2020-2025)
3.2.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Company
3.4 Key Manufacturers Vaccine for Non-infectious Meningitis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine for Non-infectious Meningitis Product Location Distribution
3.4.2 Players Vaccine for Non-infectious Meningitis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE FOR NON-INFECTIOUS MENINGITIS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine for Non-infectious Meningitis Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine for Non-infectious Meningitis Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine for Non-infectious Meningitis Sales Growth
4.4 APAC Vaccine for Non-infectious Meningitis Sales Growth
4.5 Europe Vaccine for Non-infectious Meningitis Sales Growth
4.6 Middle East & Africa Vaccine for Non-infectious Meningitis Sales Growth
5 AMERICAS
5.1 Americas Vaccine for Non-infectious Meningitis Sales by Country
5.1.1 Americas Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
5.1.2 Americas Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
5.2 Americas Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
5.3 Americas Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine for Non-infectious Meningitis Sales by Region
6.1.1 APAC Vaccine for Non-infectious Meningitis Sales by Region (2020-2025)
6.1.2 APAC Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025)
6.2 APAC Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
6.3 APAC Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine for Non-infectious Meningitis by Country
7.1.1 Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
7.1.2 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
7.2 Europe Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
7.3 Europe Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine for Non-infectious Meningitis by Country
8.1.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis
10.3 Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
10.4 Industry Chain Structure of Vaccine for Non-infectious Meningitis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine for Non-infectious Meningitis Distributors
11.3 Vaccine for Non-infectious Meningitis Customer
12 WORLD FORECAST REVIEW FOR VACCINE FOR NON-INFECTIOUS MENINGITIS BY GEOGRAPHIC REGION
12.1 Global Vaccine for Non-infectious Meningitis Market Size Forecast by Region
12.1.1 Global Vaccine for Non-infectious Meningitis Forecast by Region (2026-2031)
12.1.2 Global Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine for Non-infectious Meningitis Forecast by Type (2026-2031)
12.7 Global Vaccine for Non-infectious Meningitis Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute
13.1.1 Serum Institute Company Information
13.1.2 Serum Institute Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.1.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Serum Institute Main Business Overview
13.1.5 Serum Institute Latest Developments
13.2 Sanofi SA
13.2.1 Sanofi SA Company Information
13.2.2 Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi SA Main Business Overview
13.2.5 Sanofi SA Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.3.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Nuron Biotech
13.4.1 Nuron Biotech Company Information
13.4.2 Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nuron Biotech Main Business Overview
13.4.5 Nuron Biotech Latest Developments
13.5 JN-International Medical
13.5.1 JN-International Medical Company Information
13.5.2 JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 JN-International Medical Main Business Overview
13.5.5 JN-International Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccine for Non-infectious Meningitis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccine for Non-infectious Meningitis by Country/Region, 2020, 2024 & 2031
2.2 Vaccine for Non-infectious Meningitis Segment by Type
2.2.1 Polysaccharide Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Combination Vaccines
2.2.4 Men B Vaccines
2.3 Vaccine for Non-infectious Meningitis Sales by Type
2.3.1 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccine for Non-infectious Meningitis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Type (2020-2025)
2.4 Vaccine for Non-infectious Meningitis Segment by Application
2.4.1 Meningitis
2.4.2 Septicemia
2.4.3 Others
2.5 Vaccine for Non-infectious Meningitis Sales by Application
2.5.1 Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccine for Non-infectious Meningitis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccine for Non-infectious Meningitis Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccine for Non-infectious Meningitis Breakdown Data by Company
3.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Company (2020-2025)
3.1.2 Global Vaccine for Non-infectious Meningitis Sales Market Share by Company (2020-2025)
3.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Company (2020-2025)
3.2.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company (2020-2025)
3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Company
3.4 Key Manufacturers Vaccine for Non-infectious Meningitis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine for Non-infectious Meningitis Product Location Distribution
3.4.2 Players Vaccine for Non-infectious Meningitis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE FOR NON-INFECTIOUS MENINGITIS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine for Non-infectious Meningitis Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccine for Non-infectious Meningitis Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccine for Non-infectious Meningitis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccine for Non-infectious Meningitis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine for Non-infectious Meningitis Sales Growth
4.4 APAC Vaccine for Non-infectious Meningitis Sales Growth
4.5 Europe Vaccine for Non-infectious Meningitis Sales Growth
4.6 Middle East & Africa Vaccine for Non-infectious Meningitis Sales Growth
5 AMERICAS
5.1 Americas Vaccine for Non-infectious Meningitis Sales by Country
5.1.1 Americas Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
5.1.2 Americas Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
5.2 Americas Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
5.3 Americas Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine for Non-infectious Meningitis Sales by Region
6.1.1 APAC Vaccine for Non-infectious Meningitis Sales by Region (2020-2025)
6.1.2 APAC Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025)
6.2 APAC Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
6.3 APAC Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine for Non-infectious Meningitis by Country
7.1.1 Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
7.1.2 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
7.2 Europe Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
7.3 Europe Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine for Non-infectious Meningitis by Country
8.1.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis
10.3 Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
10.4 Industry Chain Structure of Vaccine for Non-infectious Meningitis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine for Non-infectious Meningitis Distributors
11.3 Vaccine for Non-infectious Meningitis Customer
12 WORLD FORECAST REVIEW FOR VACCINE FOR NON-INFECTIOUS MENINGITIS BY GEOGRAPHIC REGION
12.1 Global Vaccine for Non-infectious Meningitis Market Size Forecast by Region
12.1.1 Global Vaccine for Non-infectious Meningitis Forecast by Region (2026-2031)
12.1.2 Global Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccine for Non-infectious Meningitis Forecast by Type (2026-2031)
12.7 Global Vaccine for Non-infectious Meningitis Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute
13.1.1 Serum Institute Company Information
13.1.2 Serum Institute Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.1.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Serum Institute Main Business Overview
13.1.5 Serum Institute Latest Developments
13.2 Sanofi SA
13.2.1 Sanofi SA Company Information
13.2.2 Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi SA Main Business Overview
13.2.5 Sanofi SA Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.3.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Nuron Biotech
13.4.1 Nuron Biotech Company Information
13.4.2 Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nuron Biotech Main Business Overview
13.4.5 Nuron Biotech Latest Developments
13.5 JN-International Medical
13.5.1 JN-International Medical Company Information
13.5.2 JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
13.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 JN-International Medical Main Business Overview
13.5.5 JN-International Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine for Non-infectious Meningitis Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine for Non-infectious Meningitis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polysaccharide Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Combination Vaccines
Table 6. Major Players of Men B Vaccines
Table 7. Global Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 8. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Table 9. Global Vaccine for Non-infectious Meningitis Revenue by Type (2020-2025) & ($ million)
Table 10. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2025)
Table 11. Global Vaccine for Non-infectious Meningitis Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Vaccine for Non-infectious Meningitis Sale by Application (2020-2025) & (K Units)
Table 13. Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2020-2025)
Table 14. Global Vaccine for Non-infectious Meningitis Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2020-2025)
Table 16. Global Vaccine for Non-infectious Meningitis Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Vaccine for Non-infectious Meningitis Sales by Company (2020-2025) & (K Units)
Table 18. Global Vaccine for Non-infectious Meningitis Sales Market Share by Company (2020-2025)
Table 19. Global Vaccine for Non-infectious Meningitis Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company (2020-2025)
Table 21. Global Vaccine for Non-infectious Meningitis Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Vaccine for Non-infectious Meningitis Producing Area Distribution and Sales Area
Table 23. Players Vaccine for Non-infectious Meningitis Products Offered
Table 24. Vaccine for Non-infectious Meningitis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccine for Non-infectious Meningitis Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Vaccine for Non-infectious Meningitis Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vaccine for Non-infectious Meningitis Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vaccine for Non-infectious Meningitis Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vaccine for Non-infectious Meningitis Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 36. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2025)
Table 37. Americas Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 39. Americas Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 40. APAC Vaccine for Non-infectious Meningitis Sales by Region (2020-2025) & (K Units)
Table 41. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Region (2020-2025)
Table 42. APAC Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 44. APAC Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 45. Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 46. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 48. Europe Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Vaccine for Non-infectious Meningitis
Table 54. Key Market Challenges & Risks of Vaccine for Non-infectious Meningitis
Table 55. Key Industry Trends of Vaccine for Non-infectious Meningitis
Table 56. Vaccine for Non-infectious Meningitis Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccine for Non-infectious Meningitis Distributors List
Table 59. Vaccine for Non-infectious Meningitis Customer List
Table 60. Global Vaccine for Non-infectious Meningitis Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vaccine for Non-infectious Meningitis Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Vaccine for Non-infectious Meningitis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Vaccine for Non-infectious Meningitis Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Vaccine for Non-infectious Meningitis Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Serum Institute Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 75. Serum Institute Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 76. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Serum Institute Main Business
Table 78. Serum Institute Latest Developments
Table 79. Sanofi SA Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 81. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sanofi SA Main Business
Table 83. Sanofi SA Latest Developments
Table 84. Pfizer Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 86. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Nuron Biotech Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 90. Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 91. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Nuron Biotech Main Business
Table 93. Nuron Biotech Latest Developments
Table 94. JN-International Medical Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 95. JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 96. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. JN-International Medical Main Business
Table 98. JN-International Medical Latest Developments
Table 1. Vaccine for Non-infectious Meningitis Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccine for Non-infectious Meningitis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Polysaccharide Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Combination Vaccines
Table 6. Major Players of Men B Vaccines
Table 7. Global Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 8. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Table 9. Global Vaccine for Non-infectious Meningitis Revenue by Type (2020-2025) & ($ million)
Table 10. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2025)
Table 11. Global Vaccine for Non-infectious Meningitis Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Vaccine for Non-infectious Meningitis Sale by Application (2020-2025) & (K Units)
Table 13. Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2020-2025)
Table 14. Global Vaccine for Non-infectious Meningitis Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2020-2025)
Table 16. Global Vaccine for Non-infectious Meningitis Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Vaccine for Non-infectious Meningitis Sales by Company (2020-2025) & (K Units)
Table 18. Global Vaccine for Non-infectious Meningitis Sales Market Share by Company (2020-2025)
Table 19. Global Vaccine for Non-infectious Meningitis Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company (2020-2025)
Table 21. Global Vaccine for Non-infectious Meningitis Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Vaccine for Non-infectious Meningitis Producing Area Distribution and Sales Area
Table 23. Players Vaccine for Non-infectious Meningitis Products Offered
Table 24. Vaccine for Non-infectious Meningitis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccine for Non-infectious Meningitis Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Vaccine for Non-infectious Meningitis Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vaccine for Non-infectious Meningitis Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vaccine for Non-infectious Meningitis Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vaccine for Non-infectious Meningitis Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 36. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2025)
Table 37. Americas Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 39. Americas Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 40. APAC Vaccine for Non-infectious Meningitis Sales by Region (2020-2025) & (K Units)
Table 41. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Region (2020-2025)
Table 42. APAC Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 44. APAC Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 45. Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 46. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 48. Europe Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Vaccine for Non-infectious Meningitis
Table 54. Key Market Challenges & Risks of Vaccine for Non-infectious Meningitis
Table 55. Key Industry Trends of Vaccine for Non-infectious Meningitis
Table 56. Vaccine for Non-infectious Meningitis Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccine for Non-infectious Meningitis Distributors List
Table 59. Vaccine for Non-infectious Meningitis Customer List
Table 60. Global Vaccine for Non-infectious Meningitis Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vaccine for Non-infectious Meningitis Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Vaccine for Non-infectious Meningitis Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Vaccine for Non-infectious Meningitis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Vaccine for Non-infectious Meningitis Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Vaccine for Non-infectious Meningitis Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Vaccine for Non-infectious Meningitis Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Serum Institute Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 75. Serum Institute Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 76. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Serum Institute Main Business
Table 78. Serum Institute Latest Developments
Table 79. Sanofi SA Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 81. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sanofi SA Main Business
Table 83. Sanofi SA Latest Developments
Table 84. Pfizer Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 86. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Nuron Biotech Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 90. Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 91. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Nuron Biotech Main Business
Table 93. Nuron Biotech Latest Developments
Table 94. JN-International Medical Basic Information, Vaccine for Non-infectious Meningitis Manufacturing Base, Sales Area and Its Competitors
Table 95. JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolios and Specifications
Table 96. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. JN-International Medical Main Business
Table 98. JN-International Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine for Non-infectious Meningitis
Figure 2. Vaccine for Non-infectious Meningitis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine for Non-infectious Meningitis Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Vaccine for Non-infectious Meningitis Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine for Non-infectious Meningitis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2024)
Figure 10. Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Conjugate Vaccines
Figure 13. Product Picture of Combination Vaccines
Figure 14. Product Picture of Men B Vaccines
Figure 15. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type in 2025
Figure 16. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2025)
Figure 17. Vaccine for Non-infectious Meningitis Consumed in Meningitis
Figure 18. Global Vaccine for Non-infectious Meningitis Market: Meningitis (2020-2025) & (K Units)
Figure 19. Vaccine for Non-infectious Meningitis Consumed in Septicemia
Figure 20. Global Vaccine for Non-infectious Meningitis Market: Septicemia (2020-2025) & (K Units)
Figure 21. Vaccine for Non-infectious Meningitis Consumed in Others
Figure 22. Global Vaccine for Non-infectious Meningitis Market: Others (2020-2025) & (K Units)
Figure 23. Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2024)
Figure 24. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application in 2025
Figure 25. Vaccine for Non-infectious Meningitis Sales by Company in 2025 (K Units)
Figure 26. Global Vaccine for Non-infectious Meningitis Sales Market Share by Company in 2025
Figure 27. Vaccine for Non-infectious Meningitis Revenue by Company in 2025 ($ millions)
Figure 28. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company in 2025
Figure 29. Global Vaccine for Non-infectious Meningitis Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 32. Americas Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 33. APAC Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 34. APAC Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 35. Europe Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 36. Europe Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 39. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Country in 2025
Figure 40. Americas Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Figure 41. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 42. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 43. United States Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Region in 2025
Figure 48. APAC Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2020-2025)
Figure 49. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 50. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 51. China Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 55. India Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country in 2025
Figure 59. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Figure 60. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 61. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 62. Germany Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 63. France Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 70. Egypt Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis in 2025
Figure 76. Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
Figure 77. Industry Chain Structure of Vaccine for Non-infectious Meningitis
Figure 78. Channels of Distribution
Figure 79. Global Vaccine for Non-infectious Meningitis Sales Market Forecast by Region (2026-2031)
Figure 80. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Vaccine for Non-infectious Meningitis Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Vaccine for Non-infectious Meningitis Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Vaccine for Non-infectious Meningitis
Figure 2. Vaccine for Non-infectious Meningitis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine for Non-infectious Meningitis Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Vaccine for Non-infectious Meningitis Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccine for Non-infectious Meningitis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2024)
Figure 10. Vaccine for Non-infectious Meningitis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Conjugate Vaccines
Figure 13. Product Picture of Combination Vaccines
Figure 14. Product Picture of Men B Vaccines
Figure 15. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type in 2025
Figure 16. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2025)
Figure 17. Vaccine for Non-infectious Meningitis Consumed in Meningitis
Figure 18. Global Vaccine for Non-infectious Meningitis Market: Meningitis (2020-2025) & (K Units)
Figure 19. Vaccine for Non-infectious Meningitis Consumed in Septicemia
Figure 20. Global Vaccine for Non-infectious Meningitis Market: Septicemia (2020-2025) & (K Units)
Figure 21. Vaccine for Non-infectious Meningitis Consumed in Others
Figure 22. Global Vaccine for Non-infectious Meningitis Market: Others (2020-2025) & (K Units)
Figure 23. Global Vaccine for Non-infectious Meningitis Sale Market Share by Application (2024)
Figure 24. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application in 2025
Figure 25. Vaccine for Non-infectious Meningitis Sales by Company in 2025 (K Units)
Figure 26. Global Vaccine for Non-infectious Meningitis Sales Market Share by Company in 2025
Figure 27. Vaccine for Non-infectious Meningitis Revenue by Company in 2025 ($ millions)
Figure 28. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Company in 2025
Figure 29. Global Vaccine for Non-infectious Meningitis Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 32. Americas Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 33. APAC Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 34. APAC Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 35. Europe Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 36. Europe Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Vaccine for Non-infectious Meningitis Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue 2020-2025 ($ millions)
Figure 39. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Country in 2025
Figure 40. Americas Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Figure 41. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 42. Americas Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 43. United States Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Region in 2025
Figure 48. APAC Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2020-2025)
Figure 49. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 50. APAC Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 51. China Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 55. India Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country in 2025
Figure 59. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2025)
Figure 60. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 61. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 62. Germany Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 63. France Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
Figure 70. Egypt Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Vaccine for Non-infectious Meningitis Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis in 2025
Figure 76. Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
Figure 77. Industry Chain Structure of Vaccine for Non-infectious Meningitis
Figure 78. Channels of Distribution
Figure 79. Global Vaccine for Non-infectious Meningitis Sales Market Forecast by Region (2026-2031)
Figure 80. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Vaccine for Non-infectious Meningitis Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Vaccine for Non-infectious Meningitis Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Vaccine for Non-infectious Meningitis Revenue Market Share Forecast by Application (2026-2031)
